Stock Analysts

First Merchants, Ameriana Bancorp Sign $68.7M Merger Deal

Driven by a strong balance sheet and focus on improving market share, First Merchants Corporation FRME announced its second merger deal this year. The company has signed a definitive agreement under which Ameriana Bancorp will merge with First Merchants. Expected to close in the fourth quarter of 2015, the deal is still subject to regulatory approvals and consent from shareholders of Ameriana Bancorp. […]

Stock Analysts

Jacobs-Aurecon JV Secures Melbourne Metro Rail Contract

Renowned technical services company Jacobs Engineering Group Inc.’s JEC joint venture (“JV”) with premium management, engineering and specialist technical services company, Aurecon, was recently awarded a new contract for the Melbourne Metro Rail Project. The value of the contract remains undisclosed. Aurecon Jacobs Mott MacDonald (‘‘AJM’’) JV is appointed as the technical, engagement and planning advisor for the Melbourne Metro Rail Project in Victoria, Australia. […]

Stock Analysts

3 Best Performing Nasdaq Stocks in the First Half

Despite several concerns, the Nasdaq outperformed the other major benchmarks throughout the first half of 2015. While the Dow declined 1.1% and the S&P 500 registered a gain of only 0.2% in the first half, the Nasdaq surged 5.3% in the year-to-date frame. Also, the Nasdaq hit an all-time high and crossed the 5K mark for the first time since the dot com bubble in 2000 […]

Stock Analysts

Western Union Expands Digital Service in UK Via WHSmith

Western Union Co. WU will soon be launching digital kiosks in 300 WHSmith high street stores, in an effort to expand its digital money transfer platform. Western Union will activate Western Union Money Transfer® services within WHSmith high street stores which will enable customers to simply enter their transaction details at the kiosks and then proceed to a WHSmith self-checkout to pay to transfer money […]

Stock Analysts

Bayer Files Hemophilia A Drug Marketing Application in Japan

The HealthCare segment at Bayer BAYRY announced that the company has submitted a Marketing Authorization Application in Japan for BAY 81-8973, a recombinant factor VIII compound. Bayer is looking to get BAY 81-8973 approved for the treatment of patients suffering from hemophilia A. The company has submitted regulatory application for the candidate in the U.S […]

Stock Analysts

Duke Energy to Use Lithium-Ion Batteries at Notrees Project

Diversified energy company Duke Energy Corporation DUK will upgrade its 36-megawatt (MW) energy storage and power management system at Notrees Windpower Project in west Texas. This unit is presently storing energy in lead acid batteries. The company has plans to replace these batteries with lithium-ion batteries over the course of 2016. […]

Stock Analysts

Restructuring Bears Fruit for Barclays (BCS): Is It a Hold?

We issued an updated research report on global banking giant Barclays PLC BCS on Jun 30, 2015. Barclays’ ongoing restructuring and streamlining initiatives have started bearing fruits. Notably, during the first quarter of 2015, the company saw adjusted net income attributable to shareholders increasing 20% year over year […]

Stock Analysts

TE Connectivity Promises Major Benefits for FTTH Deployments

Billion-dollar global technology giant TE Connectivity TE promises gigabyte level speeds for fiber to the home (“FTTH”) networks by showcasing latest innovations at the 2015 FTTH Connect conference in Anaheim, CA. Firstly, the firm is all set to showcase a breakthrough line of fiber distribution hubs; and secondly, it will introduce its fiber indexing architecture to hasten the pace of fiber construction at the 2015 FTTH Connect. The FTTH 2015 Innovations Cheering its investors, the company recently came up with plans to unveil 3 distinct fiber technologies in the event , namely, hardened connectivity, fiber distribution solutions, and FTTH architecture. […]

Mergers & Acquisitions

Freudenberg acquires BlueSky Process Solutions

Freudenberg acquires BlueSky Process Solutions Freudenberg Oil & Gas Technologies expands its portfolio in upstream segment PR Newswire PLYMOUTH, Mich., July 1, 2015 PLYMOUTH, Mich. , July 1, 2015 /PRNewswire/ — The Freudenberg Group is strengthening its position as a global supplier for the upstream oil and gas market. The Freudenberg Oil & Gas Technologies Business Group has acquired the business of BlueSky Process Solutions Ltd., Stoney Creek, Ontario, Canada , effective June 30, 2015 . […]

Mergers & Acquisitions

EN Engineering Announces Majority Investment from General Atlantic

EN Engineering Announces Majority Investment from General Atlantic EN Engineering to build on strong momentum as leading utility engineering and consulting firm aided by investment from leading growth investor General Atlantic to partner with management and CIVC Partners on continued growth and expansion PR Newswire WARRENVILLE, Ill. and NEW YORK, July 1, 2015 WARRENVILLE, Ill. […]

Mergers & Acquisitions

The Chemours Company Completes Spin-Off from DuPont and Launches as an Independent, Publicly Traded Company

The Chemours Company Completes Spin-Off from DuPont and Launches as an Independent, Publicly Traded Company PR Newswire WILMINGTON, Del., July 1, 2015 WILMINGTON, Del. , July 1, 2015 /PRNewswire/ — The Chemours Company (“Chemours”) (NYSE: CC), a global chemical company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced today the completion of its spin-off from DuPont and its launch as an independent, publicly traded corporation. The company’s common stock will begin trading “regular way” today on the New York Stock Exchange (NYSE) under the symbol “CC” […]

Stock Analysts

Cepheid Poised on Solid Fundamentals, Pipeline Strength

On Jun 30, 2015, we issued an updated research report on California-based molecular diagnostics company Cepheid CPHD , which develops, manufactures and markets fully integrated systems for clinical and non-clinical market tests. Cepheid reported an impressive first quarter of 2015 with earnings and revenues ahead of the respective Zacks Consensus Estimate. Interestingly, Cepheid’s Non-Clinical business returned to positive top-line growth during the quarter, driven by better-than-expected bio-threat and research grant revenues that had been witnessing a downtrend over the past few quarters […]